GlassScriptPhysician profile
Suchitra V Zambare
NPI 1730354457
$4,716.16
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,306 · 2020: $217 · 2021: $285 · 2022: $1,195 · 2023: $277 · 2024: $1,436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $976 · Food and Beverage: $678 · Education: $59.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $975.97 |
| Food and Beverage | $678.12 |
| Education | $59.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,508.15 | 2022-2024 | Minimed 780g |
| Novo Nordisk INC | $890.93 | 2019-2021 | |
| Lilly USA, LLC | $347.31 | 2019-2022 | |
| Insulet Corporation | $255.28 | 2019-2022 | |
| Abbott Laboratories | $130.46 | 2019 | |
| Radius Health, INC. | $120.80 | 2019 | |
| Medtronic Minimed, INC. | $114.46 | 2019 | |
| Tandem Diabetes Care, INC. | $99.22 | 2019-2020 | |
| Valeritas, INC. | $44.14 | 2019 | |
| Merck Sharp & Dohme LLC | $39.00 | 2019 | |
| Lifescan, INC. | $29.21 | 2019 | |
| Pfizer INC. | $22.59 | 2019 | |
| Becton, Dickinson and Company | $17.13 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.81 | 2019 | |
| Sanofi-Aventis U.S. LLC | $15.58 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $15.10 | 2022 | |
| Shire North American Group INC | $13.23 | 2019 | |
| Amgen INC. | $13.05 | 2019 | |
| Mannkind Corporation | $12.38 | 2019 | |
| Xeris Pharmaceuticals, INC. | $12.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suchitra Zambare listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.